Federated Hermes, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-07 12:57 pm Sale | 2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 258,790 4.040% | -316,236 (-55.00%) | Filing |
| 2023-05-10 10:16 am Sale | 2023-04-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 575,026 9.000% | -329,271 (-36.41%) | Filing |
| 2023-02-01 12:15 pm Purchase | 2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 904,297 14.520% | 5,184 (+0.58%) | Filing |
| 2022-07-11 2:13 pm Purchase | 2022-06-30 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 899,113 14.500% | 553,406 (+160.08%) | Filing |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FEDERATED HERMES INC. FHI | 345,707 7.530% | 345,707 (New Position) | Filing |